Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: Intermediate experience in pediatric heart transplantation recipients-Reference-Cited by-同舟云学术

Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: Intermediate experience in pediatric heart transplantation recipients

Published:2010-05 Issue:3 Volume:14 Page:402-408
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:

Author:

Matthews Kathleen,Gossett Jeffrey,Kappelle Peter Vande,Jellen Gina,Pahl Elfriede

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3046.2010.01306.x/fullpdf

Reference34 articles.

1. Long-term outcomes after cardiac transplantation: An experience based on different eras of immunosuppressive therapy;John;Ann Thorac Surg,2001

2. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: Risk factors and strategies for prevention and treatment;Baran;Am J Cardiovasc Drugs,2004

3. The profile of renal function over time in a cohort of pediatric heart transplant recipients;Bharat;Pediatr Transplant,2009

4. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: A 10-year national cohort study;Lee;J Heart Lung Transplant,2007

5. Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression;Sehgal;Clin Biochem,1998

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The teammate trial: Study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score;American Heart Journal;2023-06

2. Long‐term experience using CNI‐free immunosuppression in selected paediatric heart transplant recipients;Pediatric Transplantation;2021-08-18

3. Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations;Vascular and Endovascular Surgery;2021-04-21

4. Kaposiform Hemangioendothelioma of the middle ear in a pediatric patient: Outcomes following dual therapy with Sirolimus and Vincristine;International Journal of Pediatric Otorhinolaryngology Case Reports;2020-04

5. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association;Circulation;2019-03-26